PTEN 突变和缺失与接受 AIEOP-BFM ALL 方案治疗的儿童 T 细胞急性淋巴细胞白血病复发风险增加相关
该研究分析 257 例接受 AIEOP-BFM 方案治疗的儿童 T 细胞急性淋巴细胞白血病(T-ALL)患者,PTEN 突变见于 31 例(12.1%),且与复发风险增加显著相关;PTEN 突变在无 NOTCH1 突变或 PTEN 突变合并缺失的患者中亦提示不良预后,PTEN 状态作为生物标志物可能有助于新分子分层算法的开发。
要点
- 257 例儿童 T-ALL 中 PTEN 突变 31 例(12.1%),与复发风险增加显著相关。
- PTEN 突变在无 NOTCH1 突变或 PTEN 突变合并缺失的患者中亦提示不良预后。
- PTEN 状态作为生物标志物可能有助于新分子分层算法的开发。
核心结论
- PTEN 基因组异常及生物学上 consequential 的 PTEN 失活导致 T-ALL 患者治疗反应不良;PTEN 状态作为生物标志物可能有助于新分子分层算法的开发。
研究设计与样本
- 分析 257 例接受 AIEOP-BFM ALL 方案治疗的儿童 T-ALL 患者中 PTEN 突变对结局的影响。
主要发现
- PTEN 突变见于 31 例(12.1%)患者,且与复发风险增加显著相关。
- PTEN 突变在无 NOTCH1 突变或 PTEN 突变合并缺失的患者中亦提示不良预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Notwithstanding the improvement in treatment results for paediatric T cell acute lymphoblastic leukaemia (T-ALL) it remains important to understand if genetic aberrations influence therapy response. PTEN tumour suppressor gene inactivation is a frequent event in T-ALL but its effect on patient therapy response is debatable. We analysed the effect of the presence of mutated PTEN on outcome in 257 children with T-ALL treated with Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP)-Berlin-Frankfürt-Münster (BFM) protocols. PTEN mutations were present in 31 (12·1%) patients and were significantly associated with increased risk of relapse. PTEN mutations also indicate a poor prognosis in T-ALL patients in the absence of NOTCH1 mutations or in the group of patients with co-presence of PTEN mutation and deletions. These results indicate that PTEN genomic aberrations and the biologically consequential PTEN inactivation contribute to adverse therapy response in T-ALL patients; PTEN status as a biomarker may contribute to the development of new molecularly-defined stratification algorithms.
引用
- Paganin M, Grillo MF, Silvestri D, et al. The presence of mutated and deleted PTEN is associated with an increased risk of relapse in childhood T cell acute lymphoblastic leukaemia treated with AIEOP-BFM ALL protocols. Br J Haematol. 2018. PMID: 29938780. doi:10.1111/bjh.15449
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。